Clinical Trial Update: Study Evaluating Etanercept in Patients With Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Wyeth (now a Pfizer subsidiary) sponsored a Phase 4 trial evaluating etanercept in Ankylosing Spondylitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED